Rapamycin, an mTOR inhibitor used in autoimmune diseases and cancers also improves autophagy deficiency (Su et al., 2018) and has renal protective effects in DKD (Yang et al., 2007; Mori et al., 2009). This evidence concerns the gene MTOR and autoimmune disease.